APO Research
Talk to an analyst

APO RESEARCH · REPORT

GMP Lentivirus Production Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GMP Lentivirus Production Service Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchGMP Lentivirus Production Service Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal GMP Lentivirus Production Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal GMP Lentivirus Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GMP Lentivirus Production Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal GMP Lentivirus Production Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global GMP Lentivirus Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GMP Lentivirus Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GMP Lentivirus Production Service market include AGC Biologics, Biocompare, BPS Bioscience, Charles River Laboratories, Creative Biogene, Hillgene Biopharma, OXB, ProBio CDMO and ProBioGen AG, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global GMP Lentivirus Production Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GMP Lentivirus Production Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GMP Lentivirus Production Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global GMP Lentivirus Production Service market.

GMP Lentivirus Production Service Segment by Company

AGC Biologics

Biocompare

BPS Bioscience

Charles River Laboratories

Creative Biogene

Hillgene Biopharma

OXB

ProBio CDMO

ProBioGen AG

Revvity

SK pharmteco

Thermo Fisher Scientific

VectorBuilder

VIVEbiotech

GMP Lentivirus Production Service Segment by Type

R&D and Preclinical Service

Early Clinical (Phase I/II) Service

Late Clinical and Commercial (Phase III/Launch) Service

GMP Lentivirus Production Service Segment by Application

CAR-T Therapy

Vaccine Development

Gene Editing

Others

GMP Lentivirus Production Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GMP Lentivirus Production Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the GMP Lentivirus Production Service key companies, revenue, market share, and recent developments.

3. To split the GMP Lentivirus Production Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions GMP Lentivirus Production Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GMP Lentivirus Production Service significant trends, drivers, influence factors in global and regions.

6. To analyze GMP Lentivirus Production Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Lentivirus Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GMP Lentivirus Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Lentivirus Production Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Lentivirus Production Service industry.

Chapter 3: Detailed analysis of GMP Lentivirus Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of GMP Lentivirus Production Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of GMP Lentivirus Production Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GMP Lentivirus Production Service Industry Trends Table 2. GMP Lentivirus Production Service Industry Drivers Table 3. GMP Lentivirus Production Service Industry Opportunities and Challenges Table 4. GMP Lentivirus Production Service Industry Restraints Table 5. Global GMP Lentivirus Production Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GMP Lentivirus Production Service Revenue Share by Company (2021-2026) Table 7. Global GMP Lentivirus Production Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global GMP Lentivirus Production Service Key Company Manufacturing Base & Headquarters Table 9. Global GMP Lentivirus Production Service Company, Product Type & Application Table 10. Global GMP Lentivirus Production Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global GMP Lentivirus Production Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of R&D and Preclinical Service Table 15. Significant Companies of Early Clinical (Phase I/II) Service Table 16. Significant Companies of Late Clinical and Commercial (Phase III/Launch) Service Table 17. Global GMP Lentivirus Production Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global GMP Lentivirus Production Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global GMP Lentivirus Production Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global GMP Lentivirus Production Service Sales Value Share by Type (2021-2026) Table 21. Global GMP Lentivirus Production Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of CAR-T Therapy Table 23. Significant Companies of Vaccine Development Table 24. Significant Companies of Gene Editing Table 25. Significant Companies of Others Table 26. Global GMP Lentivirus Production Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global GMP Lentivirus Production Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global GMP Lentivirus Production Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global GMP Lentivirus Production Service Sales Value Share by Application (2021-2026) Table 30. Global GMP Lentivirus Production Service Sales Value Share by Application (2027-2032) Table 31. Global GMP Lentivirus Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global GMP Lentivirus Production Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global GMP Lentivirus Production Service Sales Value Share by Region (2021-2026) Table 34. Global GMP Lentivirus Production Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global GMP Lentivirus Production Service Sales Value Share by Region (2027-2032) Table 36. Global GMP Lentivirus Production Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global GMP Lentivirus Production Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global GMP Lentivirus Production Service Sales Value Market Share by Country (2021-2026) Table 39. Global GMP Lentivirus Production Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global GMP Lentivirus Production Service Sales Value Market Share by Country (2027-2032) Table 41. AGC Biologics Company Information Table 42. AGC Biologics Business Overview Table 43. AGC Biologics GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. AGC Biologics GMP Lentivirus Production Service Product Portfolio Table 45. AGC Biologics Recent Development Table 46. Biocompare Company Information Table 47. Biocompare Business Overview Table 48. Biocompare GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Biocompare GMP Lentivirus Production Service Product Portfolio Table 50. Biocompare Recent Development Table 51. BPS Bioscience Company Information Table 52. BPS Bioscience Business Overview Table 53. BPS Bioscience GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. BPS Bioscience GMP Lentivirus Production Service Product Portfolio Table 55. BPS Bioscience Recent Development Table 56. Charles River Laboratories Company Information Table 57. Charles River Laboratories Business Overview Table 58. Charles River Laboratories GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Charles River Laboratories GMP Lentivirus Production Service Product Portfolio Table 60. Charles River Laboratories Recent Development Table 61. Creative Biogene Company Information Table 62. Creative Biogene Business Overview Table 63. Creative Biogene GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Creative Biogene GMP Lentivirus Production Service Product Portfolio Table 65. Creative Biogene Recent Development Table 66. Hillgene Biopharma Company Information Table 67. Hillgene Biopharma Business Overview Table 68. Hillgene Biopharma GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio Table 70. Hillgene Biopharma Recent Development Table 71. OXB Company Information Table 72. OXB Business Overview Table 73. OXB GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. OXB GMP Lentivirus Production Service Product Portfolio Table 75. OXB Recent Development Table 76. ProBio CDMO Company Information Table 77. ProBio CDMO Business Overview Table 78. ProBio CDMO GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ProBio CDMO GMP Lentivirus Production Service Product Portfolio Table 80. ProBio CDMO Recent Development Table 81. ProBioGen AG Company Information Table 82. ProBioGen AG Business Overview Table 83. ProBioGen AG GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. ProBioGen AG GMP Lentivirus Production Service Product Portfolio Table 85. ProBioGen AG Recent Development Table 86. Revvity Company Information Table 87. Revvity Business Overview Table 88. Revvity GMP Lentivirus Production Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Revvity GMP Lentivirus Production Service Product Portfolio Table 90. Revvity Recent Development Table 91. SK pharmteco Company Information Table 92. SK pharmteco Business Overview Table 93. SK pharmteco GMP Lentivirus Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. SK pharmteco GMP Lentivirus Production Service Product Portfolio Table 95. SK pharmteco Recent Development Table 96. Thermo Fisher Scientific Company Information Table 97. Thermo Fisher Scientific Business Overview Table 98. Thermo Fisher Scientific GMP Lentivirus Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio Table 100. Thermo Fisher Scientific Recent Development Table 101. VectorBuilder Company Information Table 102. VectorBuilder Business Overview Table 103. VectorBuilder GMP Lentivirus Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. VectorBuilder GMP Lentivirus Production Service Product Portfolio Table 105. VectorBuilder Recent Development Table 106. VIVEbiotech Company Information Table 107. VIVEbiotech Business Overview Table 108. VIVEbiotech GMP Lentivirus Production Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. VIVEbiotech GMP Lentivirus Production Service Product Portfolio Table 110. VIVEbiotech Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. GMP Lentivirus Production Service Product Image Figure 2. Global GMP Lentivirus Production Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GMP Lentivirus Production Service Market Size (2021-2032) & (US$ Million) Figure 4. Global GMP Lentivirus Production Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. R&D and Preclinical Service Image Figure 8. Early Clinical (Phase I/II) Service Image Figure 9. Late Clinical and Commercial (Phase III/Launch) Service Image Figure 10. Global GMP Lentivirus Production Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global GMP Lentivirus Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global GMP Lentivirus Production Service Sales Value Share by Type (2021-2032) Figure 13. CAR-T Therapy Image Figure 14. Vaccine Development Image Figure 15. Gene Editing Image Figure 16. Others Image Figure 17. Global GMP Lentivirus Production Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global GMP Lentivirus Production Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global GMP Lentivirus Production Service Sales Value Share by Application (2021-2032) Figure 20. Global GMP Lentivirus Production Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global GMP Lentivirus Production Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America GMP Lentivirus Production Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America GMP Lentivirus Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe GMP Lentivirus Production Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe GMP Lentivirus Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific GMP Lentivirus Production Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific GMP Lentivirus Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America GMP Lentivirus Production Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America GMP Lentivirus Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa GMP Lentivirus Production Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa GMP Lentivirus Production Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • R&D and Preclinical Service
  • Early Clinical (Phase I/II) Service
  • Late Clinical and Commercial (Phase III/Launch) Service
Applications
  • CAR-T Therapy
  • Vaccine Development
  • Gene Editing
  • Others
Companies covered
  • AGC Biologics
  • Biocompare
  • BPS Bioscience
  • Charles River Laboratories
  • Creative Biogene
  • Hillgene Biopharma
  • OXB
  • ProBio CDMO
  • ProBioGen AG
  • Revvity
  • SK pharmteco
  • Thermo Fisher Scientific
  • VectorBuilder
  • VIVEbiotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GMP Lentivirus Production Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GMP Lentivirus Production Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 GMP Lentivirus Production Service Market Dynamics
  1. 2.1 GMP Lentivirus Production Service Industry Trends
  2. 2.2 GMP Lentivirus Production Service Industry Drivers
  3. 2.3 GMP Lentivirus Production Service Industry Opportunities and Challenges
  4. 2.4 GMP Lentivirus Production Service Industry Restraints
3 GMP Lentivirus Production Service Market by Company
  1. 3.1 Global GMP Lentivirus Production Service Company Revenue Ranking in 2025
  2. 3.2 Global GMP Lentivirus Production Service Revenue by Company (2021-2026)
  3. 3.3 Global GMP Lentivirus Production Service Company Ranking (2024-2026)
  4. 3.4 Global GMP Lentivirus Production Service Company Manufacturing Base and Headquarters
  5. 3.5 Global GMP Lentivirus Production Service Company Product Type and Application
  6. 3.6 Global GMP Lentivirus Production Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global GMP Lentivirus Production Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 GMP Lentivirus Production Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 GMP Lentivirus Production Service Market by Type
  1. 4.1 GMP Lentivirus Production Service Type Introduction
  2. 4.1.1 R&D and Preclinical Service
  3. 4.1.2 Early Clinical (Phase I/II) Service
  4. 4.1.3 Late Clinical and Commercial (Phase III/Launch) Service
  5. 4.2 Global GMP Lentivirus Production Service Sales Value by Type
  6. 4.2.1 Global GMP Lentivirus Production Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global GMP Lentivirus Production Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global GMP Lentivirus Production Service Sales Value Share by Type (2021-2032)
5 GMP Lentivirus Production Service Market by Application
  1. 5.1 GMP Lentivirus Production Service Application Introduction
  2. 5.1.1 CAR-T Therapy
  3. 5.1.2 Vaccine Development
  4. 5.1.3 Gene Editing
  5. 5.1.4 Others
  6. 5.2 Global GMP Lentivirus Production Service Sales Value by Application
  7. 5.2.1 Global GMP Lentivirus Production Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GMP Lentivirus Production Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global GMP Lentivirus Production Service Sales Value Share by Application (2021-2032)
6 GMP Lentivirus Production Service Regional Value Analysis
  1. 6.1 Global GMP Lentivirus Production Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GMP Lentivirus Production Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global GMP Lentivirus Production Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global GMP Lentivirus Production Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GMP Lentivirus Production Service Sales Value (2021-2032)
  7. 6.3.2 North America GMP Lentivirus Production Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe GMP Lentivirus Production Service Sales Value (2021-2032)
  10. 6.4.2 Europe GMP Lentivirus Production Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific GMP Lentivirus Production Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific GMP Lentivirus Production Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America GMP Lentivirus Production Service Sales Value (2021-2032)
  16. 6.6.2 South America GMP Lentivirus Production Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa GMP Lentivirus Production Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa GMP Lentivirus Production Service Sales Value Share by Country, 2025 VS 2032
7 GMP Lentivirus Production Service Country-level Value Analysis
  1. 7.1 Global GMP Lentivirus Production Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GMP Lentivirus Production Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global GMP Lentivirus Production Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global GMP Lentivirus Production Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt GMP Lentivirus Production Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt GMP Lentivirus Production Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt GMP Lentivirus Production Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AGC Biologics
  2. 8.1.1 AGC Biologics Company Information
  3. 8.1.2 AGC Biologics Business Overview
  4. 8.1.3 AGC Biologics GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AGC Biologics GMP Lentivirus Production Service Product Portfolio
  6. 8.1.5 AGC Biologics Recent Developments
  7. 8.2 Biocompare
  8. 8.2.1 Biocompare Company Information
  9. 8.2.2 Biocompare Business Overview
  10. 8.2.3 Biocompare GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biocompare GMP Lentivirus Production Service Product Portfolio
  12. 8.2.5 Biocompare Recent Developments
  13. 8.3 BPS Bioscience
  14. 8.3.1 BPS Bioscience Company Information
  15. 8.3.2 BPS Bioscience Business Overview
  16. 8.3.3 BPS Bioscience GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BPS Bioscience GMP Lentivirus Production Service Product Portfolio
  18. 8.3.5 BPS Bioscience Recent Developments
  19. 8.4 Charles River Laboratories
  20. 8.4.1 Charles River Laboratories Company Information
  21. 8.4.2 Charles River Laboratories Business Overview
  22. 8.4.3 Charles River Laboratories GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Laboratories GMP Lentivirus Production Service Product Portfolio
  24. 8.4.5 Charles River Laboratories Recent Developments
  25. 8.5 Creative Biogene
  26. 8.5.1 Creative Biogene Company Information
  27. 8.5.2 Creative Biogene Business Overview
  28. 8.5.3 Creative Biogene GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biogene GMP Lentivirus Production Service Product Portfolio
  30. 8.5.5 Creative Biogene Recent Developments
  31. 8.6 Hillgene Biopharma
  32. 8.6.1 Hillgene Biopharma Company Information
  33. 8.6.2 Hillgene Biopharma Business Overview
  34. 8.6.3 Hillgene Biopharma GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio
  36. 8.6.5 Hillgene Biopharma Recent Developments
  37. 8.7 OXB
  38. 8.7.1 OXB Company Information
  39. 8.7.2 OXB Business Overview
  40. 8.7.3 OXB GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 OXB GMP Lentivirus Production Service Product Portfolio
  42. 8.7.5 OXB Recent Developments
  43. 8.8 ProBio CDMO
  44. 8.8.1 ProBio CDMO Company Information
  45. 8.8.2 ProBio CDMO Business Overview
  46. 8.8.3 ProBio CDMO GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ProBio CDMO GMP Lentivirus Production Service Product Portfolio
  48. 8.8.5 ProBio CDMO Recent Developments
  49. 8.9 ProBioGen AG
  50. 8.9.1 ProBioGen AG Company Information
  51. 8.9.2 ProBioGen AG Business Overview
  52. 8.9.3 ProBioGen AG GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ProBioGen AG GMP Lentivirus Production Service Product Portfolio
  54. 8.9.5 ProBioGen AG Recent Developments
  55. 8.10 Revvity
  56. 8.10.1 Revvity Company Information
  57. 8.10.2 Revvity Business Overview
  58. 8.10.3 Revvity GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Revvity GMP Lentivirus Production Service Product Portfolio
  60. 8.10.5 Revvity Recent Developments
  61. 8.11 SK pharmteco
  62. 8.11.1 SK pharmteco Company Information
  63. 8.11.2 SK pharmteco Business Overview
  64. 8.11.3 SK pharmteco GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SK pharmteco GMP Lentivirus Production Service Product Portfolio
  66. 8.11.5 SK pharmteco Recent Developments
  67. 8.12 Thermo Fisher Scientific
  68. 8.12.1 Thermo Fisher Scientific Company Information
  69. 8.12.2 Thermo Fisher Scientific Business Overview
  70. 8.12.3 Thermo Fisher Scientific GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio
  72. 8.12.5 Thermo Fisher Scientific Recent Developments
  73. 8.13 VectorBuilder
  74. 8.13.1 VectorBuilder Company Information
  75. 8.13.2 VectorBuilder Business Overview
  76. 8.13.3 VectorBuilder GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 VectorBuilder GMP Lentivirus Production Service Product Portfolio
  78. 8.13.5 VectorBuilder Recent Developments
  79. 8.14 VIVEbiotech
  80. 8.14.1 VIVEbiotech Company Information
  81. 8.14.2 VIVEbiotech Business Overview
  82. 8.14.3 VIVEbiotech GMP Lentivirus Production Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 VIVEbiotech GMP Lentivirus Production Service Product Portfolio
  84. 8.14.5 VIVEbiotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst